Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: A randomized, double-blind, placebo-controlled study

Cephalalgia

Volumn 33, Issue 3, 2013, Pages 202-207

  Rabe, Kasja ^a   Pageler, Lutz ^a,b   Gaul, Charly ^a,c   Lampl, Christian ^d   Kraya, Torsten ^c   Foerderreuther, Stefanie ^e   Diener, Hans Christoph ^a   Katsarava, Zaza ^a,f  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c Luther University Halle Wittenberg   (Germany)

^d Konventhospital Barmherzige Brueder   (Austria)

^e UNIVERSITY OF MUNICH   (Germany)

^f Evangelisches Krankenhaus Unna   (Germany)

Author keywords

Medication overuse headache; prednisone; withdrawal headache

Indexed keywords

PLACEBO; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; EPISODIC TENSION HEADACHE; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE; MULTICENTER STUDY; NAUSEA; PARALLEL DESIGN; PHONOPHOBIA; PHOTOPHOBIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VOMITING; WITHDRAWAL HEADACHE;

ADOLESCENT; ADULT; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS; COMORBIDITY; DOUBLE-BLIND METHOD; DRUG TOXICITY; FEMALE; GERMANY; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; PREDNISONE; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872341370     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412462638     Document Type: Article

References (16)

1. Katsarava Z, Diener HC. Medication overuse headache in Germany. Cephalagia. 2008 ; 28: 1221-1222
2. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010 ; 9: 391-401
3. Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004 ; 3: 475-483
4. Diener HC, Haab J, Peters C, et al. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache. 1990 ; 31: 205-209
5. Mathew NT. Amelioration of ergotamine withdrawal with naproxen. Headache. 1987 ; 27: 130-133
6. Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: A prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006 ; 26: 1097-1105
7. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia. 2000 ; 20: 107-113
8. Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: Comparison of strategies. Cephalalgia. 2003 ; 23: 982-993
9. Bøe MG, Mygland Å, Salvesen R. Prednisolone does not reduce withdrawal headache: A randomized, double-blind study. Neurology. 2007 ; 69: 26-31
10. Pageler L, Katsarava Z, Diener HC, et al. Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia. 2008 ; 28: 152-156
11. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004 ; 24 (Suppl. 1). 9-160
12. Gallagher RM. Emergency treatment of intractable migraine. Headache. 1986 ; 26: 74-75
13. Fritsche G, Eberl A, Katsarava Z, et al. Drug-induced headache: Long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol. 2001 ; 45: 229-235
14. Katsarava Z, Fritsche G, Muessig M, et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001 ; 57: 1694-1698
15. Göbel H, Stolze H, Heinze A, et al. Easy therapeutical management of sumatriptan-induced daily headache. Neurology. 1996 ; 47: 297-298
16. Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009 ; 29: 1021-1027